Plus Therapeutics begins treatment in REYOBIQ dose optimization trial

3 days ago 2
Read Entire Article
  1. Homepage
  2. Finance
  3. Plus Therapeutics begins treatment in REYOBIQ dose optimization trial

Related

Stacey Abrams has some advice for companies erasing DEI from their websites: ‘It’s not about the letters’

Stacey Abrams has some advice for companies erasing DEI from...

9 minutes ago 0
CEL-SCI announces pricing of $5.7 million offering

CEL-SCI announces pricing of $5.7 million offering

13 minutes ago 0
Argus initiates CoreWeave with Buy rating due to AI infrastructure demand

Argus initiates CoreWeave with Buy rating due to AI infrastr...

14 minutes ago 0
Catalyst Watch: Bank earnings rush, OPEC report, Tesla EVs get Grok, and Superman at the box office

Catalyst Watch: Bank earnings rush, OPEC report, Tesla EVs g...

16 minutes ago 0
U.S. drilling rigs drop for 11th straight week in Baker Hughes survey

U.S. drilling rigs drop for 11th straight week in Baker Hugh...

17 minutes ago 0
JPMorgan said to start charging fintechs for customer data access; PayPal stock slides

JPMorgan said to start charging fintechs for customer data a...

20 minutes ago 0
Marc Benioff says AI is radically reshaping Salesforce, and 51% of Q1 hiring was internal as thousands of employees were redeployed

Marc Benioff says AI is radically reshaping Salesforce, and ...

34 minutes ago 0
Jefferies lists out key points after Bilibili's investor day

Jefferies lists out key points after Bilibili's investor day...

35 minutes ago 0
Kraft Heinz considering split to unlock value - Wall Street Journal

Kraft Heinz considering split to unlock value - Wall Street ...

38 minutes ago 0
Nutrien downgraded at Jefferies, seeing more risks on the horizon

Nutrien downgraded at Jefferies, seeing more risks on the ho...

40 minutes ago 0
Starbucks is in the spotlight as the hunt for a partner in China continues

Starbucks is in the spotlight as the hunt for a partner in C...

49 minutes ago 0
Brookdale director slate elected amid proxy fight with Ortelius

Brookdale director slate elected amid proxy fight with Ortel...

1 hour ago 0
Quant check for consumer staple stocks before Q2 earnings

Quant check for consumer staple stocks before Q2 earnings

1 hour ago 0
U.S. budget balance unexpectedly flips to surplus in June

U.S. budget balance unexpectedly flips to surplus in June

1 hour ago 0
Exclusive: Crypto and stablecoin infrastructure startup zerohash to raise $100 million at almost $1 billion valuation

Exclusive: Crypto and stablecoin infrastructure startup zero...

1 hour ago 0
Senator Blumenthal voices concern over JetBlue, United's Blue Sky partnership

Senator Blumenthal voices concern over JetBlue, United's Blu...

1 hour ago 0
Novartis loses patent challenge to block MSN Pharma’s generic Entresto

Novartis loses patent challenge to block MSN Pharma’s generi...

1 hour ago 0
Wall Street sees 35% Canada tariff as just a negotiation tactic: ‘Tariffs are Trump’s hammer for every nail’

Wall Street sees 35% Canada tariff as just a negotiation tac...

1 hour ago 0
Tech Voices: Intel's robotics spinout, Goldman's AI coder, Tesla

Tech Voices: Intel's robotics spinout, Goldman's AI coder, T...

2 hours ago 0
Freeport-McMoRan downgraded at UBS after popping from copper tariffs

Freeport-McMoRan downgraded at UBS after popping from copper...

2 hours ago 0

Trending

1. surrey vs glamorgan
2. oneplus
3. google pixel 9 pro
4. nord ce5
5. iphone
6. athenea del castillo
7. amazon prime
8. rbi notification 2025
9. s24 ultra
10. youtube monetization update

Popular

TechCrunch Mobility: The state of EV sales and Rivian secures the next $1B from VW

TechCrunch Mobility: The state of EV sales and Rivian secure...

1 week ago 8
Castelion raises $350M Series B to scale hypersonic missile business

Castelion raises $350M Series B to scale hypersonic missile ...

1 week ago 6
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© FBT Company 2025. All rights are reserved